Postnatal sex reversal of the ovaries in mice lacking estrogen receptors α and β

Science

Volumn 286, Issue 5448, 1999, Pages 2328-2331

  Couse, J F ^a   Curtis Hewitt, S ^a   Bunch, D O ^b   Sar, M ^c   Walker, V R ^a   Davis, B J ^d   Korach, K S ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c CIIT CENTERS FOR HEALTH RESEARCH   (United States)

^d NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; GLYCOPROTEIN; MUELLERIAN INHIBITING FACTOR;

ADOLESCENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; KNOCKOUT MOUSE; MALE; MORPHOLOGY; MOUSE; NONHUMAN; OVARY DEVELOPMENT; PHENOTYPE; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; SEX TRANSFORMATION;

ANIMALS; CELL DIFFERENTIATION; CLUSTERIN; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FEMALE; GENE TARGETING; GLYCOPROTEINS; GROWTH INHIBITORS; HIGH MOBILITY GROUP PROTEINS; LUTEINIZING HORMONE; MALE; MICE; MICE, KNOCKOUT; MOLECULAR CHAPERONES; OVARY; RECEPTORS, ESTROGEN; SEMINIFEROUS TUBULES; SERTOLI CELLS; SEX REVERSAL, GONADAL; SIGNAL TRANSDUCTION; TESTICULAR HORMONES; TESTIS; TRANSCRIPTION FACTORS;

ANIMALIA;

EID: 0342445418     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: 10.1126/science.286.5448.2328     Document Type: Article

References (35)

1. J. P. Weniger, J. Dev. Physiol. 14, 303 (1990).
2. R. Fisher, K. H. Graves, A. F. Parlow, Proc. Natl. Acad. Sci. U.S.A. 95, 6965 (1998); K. M. Robertson et al., Proc. Natl. Acad. Sci. U.S.A. 96, 7986 (1999).
3. R. Fisher, K. H. Graves, A. F. Parlow, Proc. Natl. Acad. Sci. U.S.A. 95, 6965 (1998); K. M. Robertson et al., Proc. Natl. Acad. Sci. U.S.A. 96, 7986 (1999).
4. J. F. Couse and K. S. Korach, Endocr. Rev. 20, 358 (1999).
5. 2 goodness of fit = 0.40 < P <0.50; n = 115).
6. 2 goodness of fit = 0.40 < P <0.50; n = 115).
7. T.-C. J. Wu, L. Wang, Y.-J. Y. Wan, Mol. Reprod. Dev. 33, 407 (1992); T.-C. J. Wu, L Wang, Y.-J. Wan, Fertil. Steril. 59, 54 (1993); T. L. Greco, T. M. Duello, J. Gorski, Endocr. Rev. 14, 59 (1993).
8. T.-C. J. Wu, L. Wang, Y.-J. Y. Wan, Mol. Reprod. Dev. 33, 407 (1992); T.-C. J. Wu, L Wang, Y.-J. Wan, Fertil. Steril. 59, 54 (1993); T. L. Greco, T. M. Duello, J. Gorski, Endocr. Rev. 14, 59 (1993).
9. T.-C. J. Wu, L. Wang, Y.-J. Y. Wan, Mol. Reprod. Dev. 33, 407 (1992); T.-C. J. Wu, L Wang, Y.-J. Wan, Fertil. Steril. 59, 54 (1993); T. L. Greco, T. M. Duello, J. Gorski, Endocr. Rev. 14, 59 (1993).
10. A. Jost, in Mammalian Reproduction, H. Gibian and E. J. Plotz Eds. (Springer-Verlag, New York, 1970), pp. 4-32.
11. Serum LH levels in control and αβERKO mice were assayed from serum processed from whole blood collected from the inferior aorta immediately after the animal was killed. All samples were stored at -70°C until assay. Radioimmunoassays for LH were carried out on duplicate 100-μl samples as previously described [J. Lindzey et al., Endocrinology 139, 4092 (1998)]. For male mice, LH levels were measured in four or more mice per group. Levels in control mice were 0.30 (±0.07) ng/ml; in αβERKO mice, they were 1.02 (±0.79) ng/ml. For female mice, LH levels were measured in three or more mice per group, Levels in control mice were 0.17 (±0.06) ng/ml; in αβERKO mice, they were 5.52 ng/ml (±1.19) [analysis of variance (ANOVA), P < 0.001].
12. S. S. Guraya, Int. Rev. Cytol. 160, 163 (1995).
13. A. Münsterberg and R. Lovell-Badge, Development 113, 613 (1991).
14. T. Taketo, Ann. N. Y. Acad. Sci. 637, 74 (1991).
15. S. Morais da Silva et al., Nature Genet. 14, 62 (1996).
16. 32P-CTP using the following templates: The antisense riboprobe for MIS corresponds to base pairs 379 through 720 of the mouse MIS mRNA (GenBank number X63240) and was kindly provided by A. Themmen of Erasmus University of Rotterdam; the antisense riboprobe for Sox9 corresponds to the Swa I fragment of the mouse Sox9 gene and was kindly provided by B. Capel of Duke University; and the antisense riboprobe for mouse cyclophilin mRNA was generated from the pTRI-cyclophilin template (Ambion). Final protected products were electrophoresed on a 6% acrylamide, 1 X TBE, 7 M urea gel (Novex, San Diego, CA); dried; quantified with a Storm 860 Phosphorimager and accompanying software (Molecular Dynamics, Sunnyvale, CA); and then exposed to x-ray film.
17. D. J. Whitworth, Trends Endocrinol. Metab. 9, 2 (1998).
18. B. Vigier, F. Watrin, S. Magre, Development 100, 43 (1987); N. Hashimoto, R. Kubokawa, K. Yamazaki, J. Exp. Zool. 253, 61 (1990).
19. B. Vigier, F. Watrin, S. Magre, Development 100, 43 (1987); N. Hashimoto, R. Kubokawa, K. Yamazaki, J. Exp. Zool. 253, 61 (1990).
20. L. Fitzpatrick et al., Endocrinology 140, 2581 (1999); S. C. Sharma, J. W. Clemens, M. D. Pisarska, Endocrinology 140, 4320 (1999).
21. L. Fitzpatrick et al., Endocrinology 140, 2581 (1999); S. C. Sharma, J. W. Clemens, M. D. Pisarska, Endocrinology 140, 4320 (1999).
22. J. A. Flaws, R. Abbud, R. J. Mann, Biol. Reprod. 57, 1233 (1997).
23. R. R. Behringer, R. L. Cate, G. J. Froelick, Nature 345, 167 (1990).
24. T. Kuroda, M. M. Lee, R. C. Ragin, Endocrinology 129, 2985 (1991); J. A. Visser et al., Endocrinology 139, 4244 (1998).
25. T. Kuroda, M. M. Lee, R. C. Ragin, Endocrinology 129, 2985 (1991); J. A. Visser et al., Endocrinology 139, 4244 (1998).
26. D. Guerrier et al., J. Reprod. Fertil. 88, 695 (1990).
27. T. Wagner et al., Cell 79, 1111 (1994).
28. Y. Kanai and P. Koopman, Hum. Mol. Genet. 8, 691 (1999).
29. K. Yomogida et al., Development 120, 1759 (1994).
30. C. A. Blobel, C. A. Sieff, S. H. Orkin, Mol. Cell. Biol. 15, 3147 (1995).
31. M. Heikinheimo et al., Endocrinology 138, 3505 (1997).
32. M. Eddy et al., Endocrinology 137, 4796 (1996).
33. W. M. Baarends et al., Endocrinology 136, 4951 (1995).
34. M. Sar and F. Welsch, Endocrinology 140, 963 (1999).
35. We thank the following individuals for their help and suggestions during the course of these investigations: M. Yates, L. Koonce, J. Foley, J. Lindzey, J. Harrell, E. M. Eddy, Y. Mishina, and B. Capel.